455 related articles for article (PubMed ID: 27877038)
21. pH-sensitive Eudragit nanoparticles for mucosal drug delivery.
Yoo JW; Giri N; Lee CH
Int J Pharm; 2011 Jan; 403(1-2):262-7. PubMed ID: 20971177
[TBL] [Abstract][Full Text] [Related]
22. Development of keratin nanoparticles for controlled gastric mucoadhesion and drug release.
Cheng Z; Chen X; Zhai D; Gao F; Guo T; Li W; Hao S; Ji J; Wang B
J Nanobiotechnology; 2018 Mar; 16(1):24. PubMed ID: 29554910
[TBL] [Abstract][Full Text] [Related]
23. Vaginal mucoadhesive drug delivery systems.
de Araújo Pereira RR; Bruschi ML
Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
[TBL] [Abstract][Full Text] [Related]
24. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base.
Baloglu E; Karavana SY; Senyigit ZA; Guneri T
Pharm Dev Technol; 2011; 16(6):627-36. PubMed ID: 20715905
[TBL] [Abstract][Full Text] [Related]
25. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA.
Furst T; Dakwar GR; Zagato E; Lechanteur A; Remaut K; Evrard B; Braeckmans K; Piel G
J Control Release; 2016 Aug; 236():68-78. PubMed ID: 27329774
[TBL] [Abstract][Full Text] [Related]
26. Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine.
Szymańska E; Winnicka K; Amelian A; Cwalina U
Chem Pharm Bull (Tokyo); 2014; 62(2):160-7. PubMed ID: 24492586
[TBL] [Abstract][Full Text] [Related]
27. Mucoadhesive Chitosan Derivatives as Novel Drug Carriers.
Islam MA; Park TE; Reesor E; Cherukula K; Hasan A; Firdous J; Singh B; Kang SK; Choi YJ; Park IK; Cho CS
Curr Pharm Des; 2015; 21(29):4285-309. PubMed ID: 26323422
[TBL] [Abstract][Full Text] [Related]
28. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the mucoadhesive properties of chitosan nanoparticles prepared using different chitosan to tripolyphosphate (CS:TPP) ratios.
Hejjaji EMA; Smith AM; Morris GA
Int J Biol Macromol; 2018 Dec; 120(Pt B):1610-1617. PubMed ID: 30282010
[TBL] [Abstract][Full Text] [Related]
30. Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application.
Almomen A; Cho S; Yang CH; Li Z; Jarboe EA; Peterson CM; Huh KM; Janát-Amsbury MM
Pharm Res; 2015 Jul; 32(7):2266-79. PubMed ID: 25609012
[TBL] [Abstract][Full Text] [Related]
31. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
[TBL] [Abstract][Full Text] [Related]
32. The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice.
Zong S; Wang X; Yang Y; Wu W; Li H; Ma Y; Lin W; Sun T; Huang Y; Xie Z; Yue Y; Liu S; Jing X
Eur J Pharm Biopharm; 2015 Jun; 93():127-35. PubMed ID: 25843238
[TBL] [Abstract][Full Text] [Related]
33. Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs.
de Araújo PR; Calixto GMF; da Silva IC; de Paula Zago LH; Oshiro Junior JA; Pavan FR; Ribeiro AO; Fontana CR; Chorilli M
AAPS PharmSciTech; 2019 Jun; 20(6):225. PubMed ID: 31214798
[TBL] [Abstract][Full Text] [Related]
34. S-protected gellan gum: Decisive approach towards mucoadhesive antimicrobial vaginal films.
Jalil A; Asim MH; Le NN; Laffleur F; Matuszczak B; Tribus M; Bernkop-Schnürch A
Int J Biol Macromol; 2019 Jun; 130():148-157. PubMed ID: 30779984
[TBL] [Abstract][Full Text] [Related]
35. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
Wong TW; Dhanawat M; Rathbone MJ
Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of bioadhesive controlled-release gels of cidofovir for vaginal delivery.
Tuğcu-Demiröz F; Acartürk F; Özkul A
J Biomater Sci Polym Ed; 2015; 26(17):1237-55. PubMed ID: 26300445
[TBL] [Abstract][Full Text] [Related]
37. Phenylboronic acid as a glucose-responsive trigger to tune the insulin release of glycopolymer nanoparticles.
Chai Z; Ma L; Wang Y; Ren X
J Biomater Sci Polym Ed; 2016; 27(7):599-610. PubMed ID: 26765145
[TBL] [Abstract][Full Text] [Related]
38. Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles.
Mouftah S; Abdel-Mottaleb MMA; Lamprecht A
Int J Pharm; 2016 Dec; 515(1-2):565-574. PubMed ID: 27773855
[TBL] [Abstract][Full Text] [Related]
39. Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems.
Pereira MN; Reis TA; Matos BN; Cunha-Filho M; Gratieri T; Gelfuso GM
Colloids Surf B Biointerfaces; 2017 Oct; 158():222-228. PubMed ID: 28697437
[TBL] [Abstract][Full Text] [Related]
40. Chitosan nanoparticles loading oxaliplatin as a mucoadhesive topical treatment of oral tumors: Iontophoresis further enhances drug delivery ex vivo.
Matos BN; Pereira MN; Bravo MO; Cunha-Filho M; Saldanha-Araújo F; Gratieri T; Gelfuso GM
Int J Biol Macromol; 2020 Jul; 154():1265-1275. PubMed ID: 31726173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
